COMMUNIQUÉS West-GlobeNewswire

BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes
05/11/2025
POMPANO BEACH, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company specializing in placental-derived biologics for advanced wound care, today commented on the [...]
electroCore Announces Third Quarter 2025 Financial Results
05/11/2025
Net sales of $8.7 million increased 33% vs. Q3 2024; YTD net sales of $22.8 million increased 26% vs. first nine months of 2024 Cash, cash equivalents, restricted cash, and marketable securities (“Total Cash”) of $13.2 [...]
Surrozen to Present at Upcoming Healthcare Investor Conference
05/11/2025
SOUTH SAN FRANCISCO, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt [...]
Neurona Therapeutics Announces Priority Medicines (PRIME) Designation Granted by the European Medicines Agency (EMA) to NRTX-1001 in the Treatment of Drug-Resistant Focal Epilepsy
05/11/2025
EMA’s PRIME designation bolsters Neurona’s global development strategy and underscores the company’s commitment to bringing NRTX-1001 interneuron cell therapy to patients worldwide. SAN FRANCISCO, Nov. 05, 2025 (GLOBE [...]
Zevra Reports Third Quarter 2025 Financial Results and Corporate Update
05/11/2025
2025 EPS of $(0.01) Q3 2025 net revenue of $26.1 million , driven by MIPLYFFA ® net revenue of $22.4 million Company to host conference call and webcast TODAY, November 5, 2025 , at 4:30 p.m. ET CELEBRATION, Fla., Nov. [...]
Generation Bio Announces Third Quarter 2025 Financial Results
05/11/2025
CAMBRIDGE, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co . (Nasdaq: GBIO), a biotechnology company, today reported third quarter financial results. Third Quarter 2025 Financial Results Cash Position: Cash, [...]
CVRx Reports Third Quarter 2025 Financial and Operating Results
05/11/2025
MINNEAPOLIS, Nov. 05, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]
Cytek Biosciences Reports Third Quarter 2025 Financial Results
05/11/2025
FREMONT, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Cytek ® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the third [...]
ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update
05/11/2025
3Q 2025 Total Revenue of $134.2 Million, a 12% YoY Increase 3Q 2025 GAAP Net Income of $36.4 Million, a 1% YoY Increase 3Q 2025 Adjusted EBITDA (1) of $58.7 Million, a 29% YoY Increase 3Q 2025 Adjusted Net Income (2) of [...]
RxSight, Inc. Reports Third Quarter 2025 Financial Results
05/11/2025
ALISO VIEJO, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, [...]
OraSure Announces Third Quarter 2025 Financial Results
05/11/2025
BETHLEHEM, Pa., Nov. 05, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for [...]
Mineralys Therapeutics to Participate in Upcoming Investor Conferences
05/11/2025
RADNOR, Pa., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities [...]
NextCure Provides Business Update and Reports Third Quarter 2025 Financial Results
05/11/2025
BELTSVILLE, Md., Nov. 05, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class, and best-in-class therapies to [...]
FDA Warns Companies Over Illegal Marketing of Botox and Related Products
05/11/2025
Silver Spring, Md., Nov. 05, 2025 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration issued 18 warning letters to owners of websites illegally marketing unapproved and misbranded botulinum toxin products, [...]
Emerald Heights Social Accountability Committee Donates $305,000 to Support 15 Charities Benefiting Local Communities
05/11/2025
REDMOND, Wash., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Emerald Heights, a leading nonprofit senior living community, proudly announces a donation of $305,000 to 15 local charities through its Social Accountability Committee [...]
Genmab to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference in London
05/11/2025
Media Release COPENHAGEN, Denmark; November 5, 2025 Genmab A/S (Nasdaq: GMAB ) announced today that its Chief Executive Officer Jan Van de Winkel and C hief F inancial O fficer Anthony Pagano will participate in a [...]
UPDATE - MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients
05/11/2025
First-of-its-kind study represents the potential for robotic-enabled microsurgical intervention for neurodegenerative diseases, including Alzheimer’s JACKSONVILLE, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- MMI (Medical [...]
VALNEVA Déclaration d’actions et de droits de vote : 31 octobre 2025
05/11/2025
VALNEVA Déclaration d’actions et de droits de vote 31 octobre 2025 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : 6 [...]
VALNEVA Declaration of shares and voting rights: October 31, 2025
05/11/2025
VALNEVA Declaration of shares and voting rights October 31, 2025 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, [...]

Pages